Thermosensitive hydrogel for prolonged delivery of lentiviral vector expressing neurotrophin-3 in vitro
Background The development of tissue engineering scaffolds for gene delivery has the potential to enhance gene transfer efficiency and safety via controlled temporal and spatial delivery. Lentiviral delivery can be carried out using the natural biopolymer thermoresponsive gel, chitosan/β‐glycerol ph...
Gespeichert in:
Veröffentlicht in: | The journal of gene medicine 2011-11, Vol.13 (11), p.591-601 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
The development of tissue engineering scaffolds for gene delivery has the potential to enhance gene transfer efficiency and safety via controlled temporal and spatial delivery. Lentiviral delivery can be carried out using the natural biopolymer thermoresponsive gel, chitosan/β‐glycerol phosphate (β‐GP) as a carrier.
Methods
Three chitosan/β‐GP scaffolds were prepared with varying concentrations of chitosan and β‐GP to obtain a pH and gelation temperature suitable for in situ delivery. A lentiviral vector expressing either green fluorescent protein (Lenti GFP) or neurotrophin‐3 (Lenti NT‐3) was incorporated into the chitosan/β‐GP scaffolds and also into collagen 0.1% w/v (control). Viral elution medium was removed at various timepoints and added to the culture medium of pre‐seeded HeLa or primary dorsal root ganglia (DRG) cells, respectively. GFP gene expression was quantified using fluorescence‐activated cell sorting analysis. The effect of Lenti NT‐3 was analyzed by measuring DRG neurite outgrowth.
Results
Collagen displayed its most significant elution of virus on day 1 and chitosan/β‐GP (with a final concentration of 2.17% chitosan) on day 3.
Conclusions
The system shows promise for the in situ, thermoresponsive delivery of lentiviral vectors providing long‐term gene expression for therapeutic factors to treat conditions such as injury to the nervous system. Copyright © 2011 John Wiley & Sons, Ltd. |
---|---|
ISSN: | 1099-498X 1521-2254 1521-2254 |
DOI: | 10.1002/jgm.1613 |